Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice

Nagpal, 2005, Noncalcemic actions of vitamin D receptor ligands, Endocr Rev, 26, 662, 10.1210/er.2004-0002 Li, 2002, 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin–angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219 Li, 2004, Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure, J Steroid Biochem Mol Biol, 89–90, 387, 10.1016/j.jsbmb.2004.03.004 Xiang, 2005, Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin–angiotensin systems, Am J Physiol Endocrinol Metab, 288, E125, 10.1152/ajpendo.00224.2004 Bodyak, 2007, Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals, Proc Natl Acad Sci USA, 104, 16810, 10.1073/pnas.0611202104 Burgess, 1990, Interaction of 1, 25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension, Am J Hypertens, 3, 903, 10.1093/ajh/3.12.903 Kristal-Boneh, 1997, Association of calcitriol and blood pressure in normotensive men, Hypertension, 30, 1289, 10.1161/01.HYP.30.5.1289 Lind, 1995, Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men, Am J Hypertens, 8, 894, 10.1016/0895-7061(95)00154-H Resnick, 1986, Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism, Ann Intern Med, 105, 649, 10.7326/0003-4819-105-5-649 Scragg, 2007, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey, Am J Hypertens, 20, 713, 10.1016/j.amjhyper.2007.01.017 Lind, 1989, Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study, Am J Hypertens, 2, 20, 10.1093/ajh/2.1.20 Pfeifer, 2001, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab, 86, 1633 Kimura, 1999, Effectiveness of 1, 25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity, Intern Med, 38, 31, 10.2169/internalmedicine.38.31 Park, 1999, Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism, Am J Kidney Dis, 33, 73, 10.1016/S0272-6386(99)70260-X Li, 1997, Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia, Proc Natl Acad Sci USA, 94, 9831, 10.1073/pnas.94.18.9831 Yuan, 2007, 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter, J Biol Chem, 282, 29821, 10.1074/jbc.M705495200 Kong, 2003, Effect of II ANG type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice, Am J Physiol Regul Integr Comp Physiol, 285, R255, 10.1152/ajpregu.00517.2002 Panda, 2001, Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction, Proc Natl Acad Sci USA, 98, 7498, 10.1073/pnas.131029498 Dardenne, 2001, Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets, Endocrinology, 142, 3135, 10.1210/endo.142.7.8281 Erben, 2002, Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D, Mol Endocrinol, 16, 1524, 10.1210/mend.16.7.0866 Yoshizawa, 1997, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning, Nat Genet, 16, 391, 10.1038/ng0897-391 Ichihara, 2001, Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension, Circulation, 104, 346, 10.1161/01.CIR.104.3.346 Izumiya, 2003, Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling, Circ Res, 93, 874, 10.1161/01.RES.0000100665.67510.F5 Kobori, 2004, AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension, Hypertension, 43, 1126, 10.1161/01.HYP.0000122875.91100.28 Muller, 2002, Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage, Hypertension, 40, 840, 10.1161/01.HYP.0000039748.88581.A0 Goodfriend, 1996, Angiotensin receptors and their antagonists, N Engl J Med, 334, 1649, 10.1056/NEJM199606203342507 Volpe, 2002, The renin–angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease, J Am Soc Nephrol, 13, S173, 10.1097/01.ASN.0000032549.36050.78 Panda, 2004, Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis, J Biol Chem, 279, 16754, 10.1074/jbc.M310271200 Teng, 2003, Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy, N Engl J Med, 349, 446, 10.1056/NEJMoa022536 Ferreira, 2008, The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice, Am J Physiol Regul Integr Comp Physiol, 294, R26, 10.1152/ajpregu.00424.2007 Tishkoff, 2008, Functional vitamin D receptor in the T-tubules of cardiac myocytes, Endocrinology, 149, 558, 10.1210/en.2007-0805 Xue, 2005, Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development, Hum Mol Genet, 14, 1515, 10.1093/hmg/ddi160